Use of the molecular adsorbent recirculating system (MARS™) for the management of acute poisoning with or without liver failure

References

• Bernuau J, Rueff B, Benhamou JP. Fulminant and subfulminant liver failure: Definitions and causes. Semin Liver Dis 1986; 6:97–106.
   PubMed Web of Science ®Google Scholar
• O’Grady JG, Alexander GJM, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97:439–445.
   PubMed Web of Science ®Google Scholar
• Mitzner SR. Extracorporeal liver support-albumin dialysis with the molecular adsorbent recirculating system. Ann Hepatol 2011; 10:S21–S28.
   PubMedGoogle Scholar
• Pitkin Z, Mullon C. Evidence of absence of porcine endogenous retrovirus (PERV) infection in patients treated with a bioartificial liver support system. Artif Organs 1999; 23:829–833.
   PubMed Web of Science ®Google Scholar
• Mitzner SR, Stange J, Klammt S, Risler T, Erley CM, Bader BD, . Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial. Liver Transpl 2000; 6:277–286.
   PubMed Web of Science ®Google Scholar
• Heemann U, Treichel U, Loock J, Philipp T, Gerken G, Malago M, . Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study. Hepatology 2002; 36:949–958.
   PubMed Web of Science ®Google Scholar
• Sen S, Mookerjee RP, Cheshire LM, Davies NA, Williams R, Jalan R. Albumin dialysis reduces portal pressure acutely in patients with severe alcoholic hepatitis. J Hepatol 2005; 43:142–148.
   PubMed Web of Science ®Google Scholar
• Schmidt LE, Svendsen LB, Sorensen VR, Hansen BA, Larsen FS. Cerebral blood flow velocity increases during a single treatment with the Molecular Adsorbent Recirculating System in patients with acute on chronic liver failure. Liver Transpl 2001; 7:709–712.
   PubMed Web of Science ®Google Scholar
• Laleman W, Wilmer A, Evenepoel P, Verslype C, Fevery J, Nevens F. Review article: non-biological liver support in liver failure. Aliment Pharmacol Ther 2006; 23:351–363.
   PubMed Web of Science ®Google Scholar
• Kantola T, Koivusalo AM, Höckerstedt K, Isoniemi H. The effect of molecular adsorbent recirculating system treatment on survival, native liver recovery, and need for liver transplantation in acute liver failure patients. Transpl Int 2008; 21:857–866.
   PubMed Web of Science ®Google Scholar
• Saliba F, Camus C, Durand F, Mathurin P, Delafosse B, Barange K, . Etude prospective, randomisée, multicentrique, évaluant l'efficacité et la tolérance du système de dialyse MARS chez les patients atteints d'une hépatite fulminante en attente de transplantation. Gastroenterol Clin Biol 2009; 33:A145.
   Google Scholar
• Schmidt LE, Wang LP, Hansen BA, Larsen FS. Systemic hemodynamic effects of treatment with the molecular adsorbent recirculating system in patients with hyperacute liver failure: a prospective controlled trial. Liver Transpl 2003; 9:290–297.
   PubMed Web of Science ®Google Scholar
• Ben Abraham R, Szold O, Merhav H, Biderman P, Kidron A, Nakache R, . Rapid resolution of brain edema and improved cerebral perfusion pressure following the molecular adsorbent recycling system in acute liver failure patients. Transplant Proc 2001; 33:2897–2899.
   PubMed Web of Science ®Google Scholar
• Record CO, Buxton B, Chase RA, Curzon G, Murray-Lyon IM, Williams R. Plasma and brain amino acids in fulminant hepatic failure and their relationship to hepatic encephalopathy. Eur J Clin Invest 1976; 6:387–394.
   PubMed Web of Science ®Google Scholar
• Fischer JE, Funovics JM, Aguirre A, James JH, Keane JM, Wesdorp RI, . The role of plasma amino acids in hepatic encephalopathy. Surgery 1975; 78:279–290.
   Google Scholar
• Awad SS, Swaniker F, Magee J, Punch J, Bartlett RH. Results of a phase I trial evaluating a liver support device utilizing albumin dialysis. Surgery 2001; 130:354–362.
   PubMed Web of Science ®Google Scholar
• Loock J, Mitzner SR, Peters E, Scmidt R, Stange J. Amino acid dysbalance in liver failure is favourably influenced by recirculating albumin dialysis (MARS). Liver 2002; 22:35–39.
   PubMedGoogle Scholar
• Schmidt LE, Tofteng F, Strauss GI, Larsen FS. Effect of treatment with the Molecular Adsorbents Recirculating System on arterial amino acid levels and cerebral amino acid metabolism in patients with hepatic encephalopathy. Scand J Gastroenterol 2004; 39:974–980.
   PubMed Web of Science ®Google Scholar
• Koivusalo AM, Teikari T, Höckerstedt K, Isoniemi H. Albumin dialysis has a favorable effect on amino acid profile in hepatic encephalopathy. Metab Brain Dis 2008; 23:387–398.
   PubMed Web of Science ®Google Scholar
• Mitzner SR, Stange J, Klammt S, Peszynski P, Schmidt R, Noeldge-Schomburg G. Extracorporeal detoxification using the molecular adsorbent recirculating system for critically ill patient with liver failure. J Am Soc Nephrol 2001; 12:S75–S82.
   PubMed Web of Science ®Google Scholar
• Mitzner SR, Stange J, Klammt S, Peszynski P, Schmidt R. Albumin dialysis using the MARS system. Curr Opin Nephrol Hypertens 2001; 10:777–783.
   PubMed Web of Science ®Google Scholar
• Guo LM, Liu JY, Xu DZ, Li BS, Han H, Wang LH, . Application of Molecular Adorbent Recirculating System to remove NO and cytokines in severe liver failure patients with multiple organ dysfunction syndrome. Liver Int 2003; 23(S3):16–20.
   PubMedGoogle Scholar
• Sen S, Davies NA, Mookerjee RP, Cheshire LM, Hodges SJ, Williams R, Jalan R. Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: a prospective randomised controlled study. Liver Transpl 2004; 10:1109–1119.
   PubMed Web of Science ®Google Scholar
• Di Campli C, Zocco MA, Gaspari R, Novi M, Candelli M, Santoliquido A, . The decrease in cytokine concentration during albumin dialysis correlates with the prognosis of patients with acute on chronic liver failure. Transpl Proceed 2005; 37:2551–2553.
   PubMed Web of Science ®Google Scholar
• Auth MK, Kim HS, Beste M, Bonzel KE, Baumann U, Ballauff A, . Removal of metabolites, cytokines and hepatic growth factors by extracorporeal liver support in children. J Ped Gastoenterol Nutr 2005; 40:54–59.
   PubMed Web of Science ®Google Scholar
• Novelli G, Amnesini MC, Morabito V, Cinti P, Pugliese F, Novelli S, . Cytokine level modifications: molecular adsorbent recirculating system versus standard medical therapy. Transplant Proc 2009; 41:1243–1248.
   PubMed Web of Science ®Google Scholar
• Isionemi H, Koivusalo AM, Repo H, Ilonen I, Höckerstedt K. The effect of albumin dialysis on cytokine levels in acute liver failure and need for liver transplantation. Transpl Proceed 2005; 37:1088–1090.
   PubMed Web of Science ®Google Scholar
• Falkenhagen D, Strobl W, Vogt G, Schrefl A, Linsberger I, Gerner FJ, . Fractionated Plasma Separation and Adsorption System: A Novel System for Blood Purification to Remove Albumin Bound Substances. Artif Organs 1999; 23:81–86.
   PubMed Web of Science ®Google Scholar
• Evenepoel P, Laleman W, Wilmer A, Claes K, Kuypers D, Bammens B, . Prometheus Versus Molecular Adsorbent Recirculating System: Comparison of Efficiency in Two Different Liver Detoxification Devices. Artif Organs 2006; 30:276–284.
   PubMed Web of Science ®Google Scholar
• Rifai K, Ernst T, Kretschmer U, Haller H, Manns MP, Fliser D. Removal selectivity of Prometheus: A new extracorporeal liver support device. World J Gastroenterol 2006; 12:940–944.
   PubMed Web of Science ®Google Scholar
• Peszynski P, Stange J, Mitzner S, Klammt S, Majcher-Peszynska J. Wacke R, et al. Removal of benzodiazepine-like substances as a cause of improvement of hepatic encephalopathy during albumin dialysis. Z Gastroenterol 2001; 39:53.
   Google Scholar
• Sen S, Ytrebo LM, Rose C, Fuskevaag OM, Davies NA, Nedredal GI, . Albumin dialysis: a new therapeutic strategy for intoxication from protein-bound drugs. Intensive Care Med 2004; 30:496–501.
   PubMed Web of Science ®Google Scholar
• Pugliese F, Novelli G, Poli L, Levi Sandri GB, Di Folco G, Ferretti S, . Hemodynamic improvement as an additional parameter to evaluate the safety and tolerability of the Molecular Adsorbent Recirculating System in liver failure patients. Transplant Proc 2008; 40: 1925–1928.
   PubMed Web of Science ®Google Scholar
• Lai WK, Haydon G, Mutimer D, Murphy N. The effect of molecular adsorbent recirculating system on pathophysiological parameters in patients with acute liver failure. Intensive Care Med 2005; 31: 1544–1549.
   PubMed Web of Science ®Google Scholar
• Sen S, Rose C, Ytrebo LM, Davies NA, Nedredal GI, Drevland SS, . Effect of albumin dialysis on intracranial pressure increase in pigs with acute liver failure: a randomised study. Crit Care Med 2006; 34:158–164.
   PubMed Web of Science ®Google Scholar
• Sorkine P, Ben Abraham R, Szold O, Biderman P, Kidron A, Merchav H, Role of the molecular adsorbent recycling system (MARS) in the treatment of patients with acute exacerbation of chronic liver failure. Crit Care Med 2001; 29:1332–1336.
   PubMed Web of Science ®Google Scholar
• Siewert-Delle A, Henriksson BA, Backman L. Albumin dialysis with the M.A.R.S. (Molecular Absorbent Recirculating System) for a patient with acute liver failure due to paracetamol intoxication: a case report. Z Gastroenterol 2001; 39:48.
   Google Scholar
• Pugliese F, Ruberto F, Perrella SM, Cappannoli A, Bruno K, Martelli S, . Modifications of intracranial pressure after molecular adsorbent recirculating system treatment in patients with acute liver failure: case reports. Transplant Proc 2007; 39:2042–2044.
   PubMed Web of Science ®Google Scholar
• Novelli G, Rossi M, Pretagostini R, Ferretti G, Novelli S, Ianni S, . A 3-year experience with molecular adsorbent recirculating system (MARS): Our results on 63 patients with hepatic failure and color Doppler US evaluation of cerebral perfusion. Liver Int 2003; 23:10–15.
   PubMed Web of Science ®Google Scholar
• Novelli G, Rossi M, Pretagostini M, Pugliese F, Ruberto F, Novelli L, . One hundred sixteen cases of acute liver failure treated with MARS. Transpl Proc 2005; 37:2557–2559.
   PubMed Web of Science ®Google Scholar
• Sussman NL, Chong MG, Koussayer T, He DE, Shang TA, Whisennand HA, Kelly JH. Reversal of fulminant hepatic failure using an extracorporeal liver assist device. Hepatology 1992; 16:60–65.
   PubMed Web of Science ®Google Scholar
• Ellis AJ, Hughes RD, Wendon JA, Dunne J, Langley PG, Kelly JH, . Pilot-Controlled Trial of the Extracorporeal Liver Assist Device in Acute Liver Failure. Hepatology 1996; 24:1446–1451.
   PubMed Web of Science ®Google Scholar
• Demetriou AA, Brown RS Jr, Busutill RW, Fair J, McGuire BM, Rosenthal P, . Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg 2004; 239:660–667.
   PubMed Web of Science ®Google Scholar
• McIntyre CW, Fluck RJ, Freeman JG, Lambie SH. Use of albumin dialysis in the treatment of hepatic and renal dysfunction due to paracetamol intoxication. Nephrol Dial Transplant 2002; 17:316–317.
   PubMed Web of Science ®Google Scholar
• Banares Cazinares R, Catalina Rodriguez MV. Indications and therapeutic possibilities of albumin dialysis (MARS). Rev Esp Enferm Dig 2003; 95:876–89.
   PubMedGoogle Scholar
• Felldin M, Friman S, Backman L, Siewert-Delle A, Henriksson BA, Larsson B, Olausson M. Treatment with the molecular adsorbent recirculating system in patients with acute liver failure. Transplant Proc 2003; 35:822-823.
   PubMed Web of Science ®Google Scholar
• Koivusalo AM, Yldirim Y, Vakkuri A, Lindgren L, Höckerstedt K, Isionemi H. Experience with albumin dialysis in five patients with severe overdoses of paracetamol. Acta Anaesthesiol Scand 2003; 47:1145–1150.
   PubMed Web of Science ®Google Scholar
• Hydzik P, Drozdz M, Sulowicz W, Groszek B. Liver albumin dialysis – application in acetaminophen poisoning. Przegl Lek 2004; 61:377–382.
   PubMedGoogle Scholar
• Lubezky N, Nakache R, Carmiel M, Oren R, Sorkine P, Klausner J, Ben-Haim M. Initial experience with urgent adult-to-adult living donor liver transplantation in fulminant hepatic failure. Isr Med Assoc J 2004; 6:467–470.
   PubMed Web of Science ®Google Scholar
• Zhou XM, Miao JY, Yang Y, Zhao L, Wang X, Xu L, . Clinical Experience with Molecular Adsorbent Recirculating System (MARS) in Patients with Drug-induced Liver Failure. Artif Organs 2004; 28:483–486.
   PubMed Web of Science ®Google Scholar
• Camus C, Lavoué S, Gacouin A, Le Tulzo Y, Lorho R, Boudjéma K, . Molecular adsorbent recirculating system dialysis in patients with acute liver failure who are assessed for liver transplantation. Intensive Care Med 2006; 32:1817–1825.
   PubMed Web of Science ®Google Scholar
• Kantola T, Koivusalo AM, Höckerstedt K, Isionemi H. The effect of molecular adsorbent recirculating system treatment on survival, native liver recovery, and need for liver transplantation in acute liver failure patients. Transpl Int 2008; 21:857–66.
   PubMed Web of Science ®Google Scholar
• Novelli G, Rossi M, Morabito V, Pugliese F, Ruberto F, Perrella SM, . Pediatric acute liver failure with molecular adsorbent recirculating system treatment. Transplant Proc 2008; 40:1921–1924.
   PubMed Web of Science ®Google Scholar
• Camus C, Lavoué S, Gacouin A, Compagnon P, Boudjéma K, Jacquelinet C, . Liver transplantation avoided in patients with fulminant hepatic failure who received albumin dialysis with the molecular adsorbent recirculating system while on the waiting list: impact of the duration of therapy. Ther Apher Dial 2009; 13: 549–55.
   PubMed Web of Science ®Google Scholar
• Kantola T, Koivusalo A.M., Parmanen S, Höckerstedt K, Isoniemi H. Survival predictors in patients treated with a molecular adsorbent recirculating system. World J Gastroenterol 2009; 15:3015–3024.
   PubMed Web of Science ®Google Scholar
• Koivusalo AM, Kantola T, Arola J, Höckerstedt K, Kairaluoma P, Isionemi H. Is it possible to gain extra waiting time to liver transplantation in acute liver failure patients using albumin dialysis? Ther Apher Dial 2009; 13:556.
   Web of Science ®Google Scholar
• de Geus H, Mathôt R, van der Hoven B, Tjoa M, Bakker J. Enhanced paracetamol clearance with molecular adsorbents recirculating system (MARS) in severe autointoxication. Blood Purif 2010; 30:118–119.
   PubMed Web of Science ®Google Scholar
• Kantola T, Ilmakunnas M, Koivusalo AM, Isionemi H. Bridging therapies and liver transplantation in acute liver failure, 10 years of MARS experience in Finland. Scand J Surg 2011; 100: 8–13.
   PubMed Web of Science ®Google Scholar
• Skwarek A, Grodzicki M, Nyckowski P, Kotulski M, Zieniewicz K, Michalowicz B, . The Use Prometheus FPSA System in the Treatment of Acute Liver Failure: Preliminary Results. Transpl Proc 2006; 38:209–211.
   PubMed Web of Science ®Google Scholar
• Karvellas CJ, Bagshaw SM, McDermid RC, Stollery DE, Gibney RT. Acetaminophen-induced acute liver failure treated with single-pass albumin dialysis: report of a case. Int J Artif Organs 2008; 31:450–455.
   PubMed Web of Science ®Google Scholar
• Karvellas CJ, Bagshaw SM, McDermid RC, Stollery DE, Bain VG, Gibney RT. A case-control study of single-pass albumin dialysis for acetaminophen-induced acute liver failure. Blood Purif 2009; 28:151–158.
   PubMed Web of Science ®Google Scholar
• Faulstich H. Mushroom poisoning. Lancet 1980; 2:794–795.
   PubMed Web of Science ®Google Scholar
• Wieland T. The toxic peptides from Amanita mushrooms. Int J Pept Protein Res 1983; 22:257–276.
   PubMedGoogle Scholar
• Leist M, Gantner F, Naumann H, Bluethmann H, Vogt K, Brigelius-Flohé R, . Tumor necrosis factor-induced apoptosis during the poisoning of mice with hepatotoxins. Gastroenterology 1997; 112:923–934.
   PubMed Web of Science ®Google Scholar
• Jaeger A, Jehl F, Flesch F, Sauder P, Kopferschmitt J. Kinetics of amatoxins in human poisoning: therapeutic implications. J Toxicol Clin Toxicol 1993; 31:63–80.
   PubMed Web of Science ®Google Scholar
• Von Clarmann M, Mathes G, Weber T, Erhardt W, Kircher G, Fischer M. Therapy of Amanita phalloides poisoning. Results of clinical and experimental studies. Fortschr Med 1979; 97:1999–2005.
   PubMedGoogle Scholar
• Jander S, Bischoff J, Woodcock BG. Plasmapheresis in the treatment of Amanita phalloides poisoning: a review and recommendations. Ther Apher 2000; 4:308–312.
   PubMedGoogle Scholar
• Shi Y, He J, Chen S, Zhang L, Yang X, Wang Z, Wang M. MARS: optimistic therapy method in fulminant hepatic failure secondary to cytotoxic mushroom poisoning – a case report. Liver 2002; 22:78–80.
   PubMedGoogle Scholar
• Catalina MV, Nunez O, Ponferrada A, Menchen L, Matilla A, Clemente G, Banares R. Liver failure due to mushroom poisoning: clinical course and new treatment perspectives. Gastroenterol Hepatol 2003; 26:417–420.
   PubMedGoogle Scholar
• Covic A, Goldsmith DJA, Gusbeth-Tatomir P, Volovat C, Dimitriu AG, Cristogel F, Bizo A. Successful use of Molecular Absorbent Regenerating System (MARS) dialysis for the treatment of fulminant hepatic failure in children accidentally poisoned by toxic mushroom ingestion. Liver Int 2003; 23:21–27.
   PubMed Web of Science ®Google Scholar
• Faybik P, Hetz H, Baker A, Bittermann C, Berlakovich G, Werba A, . Extracorporeal albumin dialysis in patients with Amanita phalloides poisoning. Liver Int 2003; 23:28–33.
   PubMed Web of Science ®Google Scholar
• Rubik J, Pietraszek-Jezierska E, Kaminski A, Skarzynska A, Jozwiak S, Pawlowska J, . Successful treatment of a child with fulminant liver failure and coma caused by Amanita phalloides intoxication with albumin dialysis without liver transplantation. Pediatr Transplant 2004; 8:295–300.
   PubMed Web of Science ®Google Scholar
• Wu BF, Wang MM. Molecular adsorbent recirculating system in dealing with maternal Amanita poisoning during the second pregnancy trimester: a case report. Hepatobiliary Pancreat Dis Int 2004; 3:152–154.
   PubMedGoogle Scholar
• Hydzik P, Gawlikowski T, Ciszowski K, Kwella N, Sein Anand J, Wojcicki M, . Liver albumin dialysis (MARS) – treatment of choice in Amanita phalloides poisoning? Przegl Lek 2005; 62:475–479.
   PubMedGoogle Scholar
• Lionte C, Sorodoc L, Simionescu V. Successful treatment of an adult with Amanita phalloides – induced fulminant liver failure with Molecular Adsorbent Recirculating System. Rom J Gastroenterol 2005; 14:267–271.
   PubMedGoogle Scholar
• Sein Anand J, Chodorowski Z, Hydzik P. Molecular Adsorbent Recirculating System – MARS as a bridge to liver transplantation in Amanita phalloides intoxication. Przegl Lek 2005; 62:480–481.
   PubMedGoogle Scholar
• Sein Anand J, Chodorowski Z, Wisniewski M, Waldman W. The assessment of albumin liver dialysis—MARS efficacy in the treatment of Amanita phalloides poisoning. Przegl Lek 2007; 64:255–257.
   PubMedGoogle Scholar
• Wisniewski M, Lukasik-Glebocka M, Chodorowski Z, Sein Anand J. Albumin dialysis (MARS) vs standard therapy in management of Amanita phalloides poisoning (Abstract). Clin Toxicol 2008; 46:402–403.
   Web of Science ®Google Scholar
• Wisniewski M, Sein Anand J, Hydzik P, Barwina M, Waldman W, Chodorowski Z. Outcome predictors in patients treated with albumin dialysis due to Amanita phalloides poisoning (Abstract). Clin Toxicol 2008; 46:408.
   Web of Science ®Google Scholar
• Kantola T, Kantola T, Koivusalo AM, Höckerstedt K, Isionemi H. Early molecular adsorbents recirculating system treatment in Amanita mushroom poisoning. Ther Apher Dial 2009; 13:399–403.
   PubMed Web of Science ®Google Scholar
• Sorodoc L, Lionte C, Sorodoc V, Petris O, Jaba I. Is MARS system enough for A. phalloides-induced liver failure treatment. Hum Exp Toxicol 2010; 29:823–832.
   PubMed Web of Science ®Google Scholar
• Kramer L, Bauer E, Schenk P, Steininger R, Vigl M, Mallek R. Successful treatment of refractory cerebral edema in ecstasy/ cocaine-induced fulminant hepatic failure using a new high-efficacy liver detoxification device (FPSA-Prometheus). Wien Klin Wochenschr 2003; 115:599–603.
   PubMed Web of Science ®Google Scholar
• Sein Anand J, Chodorowski Z, Wiśniewski M. Molecular Adsorbent Recirculating System (MARS) a helpful procedure in acute liver failure caused by synthetic amphetamines intoxication. Przegl Lek 2006; 63:514–515.
   Google Scholar
• Choi JY, Bae SH, Yoon SK, Cho SH, Yang JM, Han JY, . Preconditioning by extracorporeal liver support (MARS) of patients with cirrhosis and severe liver failure evaluated for living donor transplantation – a pilot study. Liver Int 2005; 25:740–745.
   PubMed Web of Science ®Google Scholar
• Lee KH, Lee MK, Sutedja DS, Lim SJ. Outcome from molecular adsorbent recycling system (MARS) liver dialysis following drug-induced liver failure. Liver Int 2005; 25:973–977.
   PubMed Web of Science ®Google Scholar
• Yang WS, Tan HK, Lui HF, Chow PK, Choong HL, Wong KS. Albumin dialysis in critically ill patients: use versus omission of intradialytic heparin. Artif Organs 2008; 32:411–416.
   PubMed Web of Science ®Google Scholar
• Doria C, Mandala L, Scott VL, Gruttadauria S, Marino IR. Fulminant Hepatic Failure Bridged to Liver Transplantation with a Molecular Adsorbent Recirculating System: A Single-Centre Experience. Dig Dis Sci 2006; 51:47–53.
   PubMed Web of Science ®Google Scholar
• Page M, Christin F, Hayi-Slayman D, Baillon JJ, Ber CE, Delafosse B, . Acute liver failure due to nimesulide: another case and review. Ann Fr Anesth Rean 2008; 27:242–246.
   Google Scholar
• Braun RC, Birck R, Singer MV, Schnuelle P, van der Woude FJ, Löhr M. Life-threatening intoxication with methylene-bis(thiocyanate): clinical picture and pitfalls. A case report. BMC Emerg Med 2006; 6:5.
   PubMedGoogle Scholar
• Fagugli RM, Gentile G, Ferrara G, Brugnano R. Acute renal and hepatic failure associated with allopurinol treatment. Clin Nephrol 2008; 70:523–536.
   PubMed Web of Science ®Google Scholar
• Chua HC, Venketasubramanian N, Tjia H, Tchan SP. Elimination of phenytoin in toxic overdose. Clin Neurol Neurosurg 2000; 102:6–8.
   PubMed Web of Science ®Google Scholar
• Martin E, Gambertoglio JG, Adler DS, Tozer TN, Roman LA, Grausz H. Removal of phenytoin by hemodialysis in uremic patients. JAMA 1977; 238:1750–1753.
   PubMed Web of Science ®Google Scholar
• Sen S, Ratnaraj N, Davies NA, Mookerjee RP, Cooper CE, Patsalos PN, . Treatment of Phenytoin Toxicity with the Molecular Adsorbent Recirculating System (MARS). Epilepsia 2003; 44:265–267.
   PubMed Web of Science ®Google Scholar
• De Schoenmakere G, De Waele J, Terryn W, Deweweire M, Verstraete A, Hoste E, . Phenytoin Intoxication in Criticall Ill Patient. Am J Kidney Dis 2004; 45:189–192.
   Web of Science ®Google Scholar
• Brodie MJ. Lamotrigine. Lancet 1992; 339:1397–400.
   PubMed Web of Science ®Google Scholar
• Mecarelli O, Pulitano P, Mingoia M, Ferretti G, Rossi M, Berloco PB, Muda AO. Acute Hepatitis Associated with Lamotrigin and Managed with the Molecular Adsorbent Recirculating System (MARS). Epilepsia 2005; 46:1687–1689.
   PubMed Web of Science ®Google Scholar
• Lee CS, Marbury TC, Perrin JH, Fuller TJ. Hemodialysis of theophyllin in uremic patients. J Clin Pharmacol.1979; 19:219–226.
   PubMed Web of Science ®Google Scholar
• Stange J, Ramlow W, Mitzner S, Schmidt R, Klinkmann H. Dialysis against a recycled albumin solution enables the removal of albumin-bound toxins. Artif Organs 1993; 17:809–813.
   PubMed Web of Science ®Google Scholar
• Korsheed S, Selby NM, Fluck RJ. Treatment of severe theophylline poisoning with the molecular adsorbent recirculating system (MARS). Nephrol Dial Transplant 2007; 22:969–970.
   PubMed Web of Science ®Google Scholar
• Higgins RM, Hearing S, Goldsmith DJ, Keevil B, Venning MC, Ackrill P. Severe theophylline poisoning: charcoal haemoperfusion or haemodialysis. Postgrad Med J 1995; 71:224–226.
   PubMed Web of Science ®Google Scholar
• Shepherd G. Treatment of poisoning caused by beta-adrenergic and calcium-channel blockers. Am J Health Syst Pharm 2006; 63:1828–1835.
   PubMed Web of Science ®Google Scholar
• Bloedow DC, Piepho RW, Nies AS, Gal J. Serum binding of diltiazem in humans. J Clin Pharmacol 1982; 22:201–205.
   PubMed Web of Science ®Google Scholar
• Pichon N, François B, Chevreuil C, Gaulier JM. Albumin dialysis: a new therapeutic alternative for severe diltiazem intoxication. Clin Toxicol 2006; 44:195–196.
   PubMed Web of Science ®Google Scholar
• Prokurat S, Grenda R, Lipowski D, Kalicinski P, Migdal M. MARS procedure as a bride to combined kidney-liver transplantation in severe chromium-copper acute intoxication: a paediatric case report. Liver 2002; 22:76–77.
   PubMedGoogle Scholar
• Kreymann B, Seyge M, Schweigart U, Kopp KF, Classen M. Albumin dialysis: effective removal of copper in a patient with fulminant Wilson disease and successful bridging to liver transplantation: a new possibility for the elimination of protein-bound toxins. J Hepatol 1999; 31:1080–1085.
   PubMed Web of Science ®Google Scholar